Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 376,346 | 440,664 | 900,570 | 875,486 | 398,005 |
| Marketable Securities | 241,984 | 240,889 | 108,119 | 69,706 | 268,368 |
| Receivables | 148,949 | 186,083 | 175,738 | 144,472 | 121,395 |
| Inventories | 262,100 | 237,532 | 222,833 | 199,452 | 204,444 |
| Income taxes - deferred | 30,880 | 31,203 | 31,203 | N/A | 29,149 |
| Other current assets | 115,330 | 77,558 | 84,265 | 108,524 | 56,458 |
| TOTAL | $1,175,589 | $1,213,929 | $1,522,728 | $1,397,640 | $1,077,819 |
| Non-Current Assets | |||||
| PPE Net | 604,513 | 568,051 | 538,117 | 523,516 | 486,741 |
| Investments And Advances | 514,381 | 509,627 | 224,810 | 97,856 | 449,143 |
| Intangibles | 1,123,335 | 1,126,253 | 1,129,288 | 210,836 | 214,207 |
| Other Non-Current Assets | 207,035 | 230,829 | 243,743 | 245,531 | 212,523 |
| TOTAL | $2,449,264 | $2,434,760 | $2,135,958 | $1,077,739 | $1,362,614 |
| Total Assets | $3,624,853 | $3,648,689 | $3,658,686 | $2,475,379 | $2,440,433 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 390,491 | 347,704 | 305,506 | 235,739 | 206,550 |
| TOTAL | $390,491 | $347,704 | $305,506 | $235,739 | $206,550 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 748,520 | 750,826 | 734,523 | 711,746 | 725,441 |
| TOTAL | $941,722 | $944,028 | $927,725 | $711,746 | $725,441 |
| Total Liabilities | $1,332,213 | $1,291,732 | $1,233,231 | $947,485 | $931,991 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 161,252 | 161,094 | 160,337 | 159,136 | 147,466 |
| Common Shares | 162 | 161 | 161 | 149 | 148 |
| Retained earnings | -1,090,186 | -999,260 | -917,271 | -849,770 | -779,973 |
| Other shareholders' equity | 11,287 | 18,553 | 34,428 | 17,771 | 9,506 |
| TOTAL | $2,292,640 | $2,356,957 | $2,425,455 | $1,527,894 | $1,508,442 |
| Total Liabilities And Equity | $3,624,853 | $3,648,689 | $3,658,686 | $2,475,379 | $2,440,433 |